Davis v Wilson [2025] FCA 108

Davis v Wilson [2025] FCA 108

Applicants failed to establish that the assumptions used in the DCF Model for valuing biological assets were unrealistic and materially overstated the accounts as alleged. The factual predicates for misleading or deceptive conduct were not established, and the counterfactual case upon which causation and loss depended was not made out. Accordingly, liability under the Corporations Act, ASIC Act, and at common law was not established.

Parties
First Applicant: MR GEOFFREY PETER DAVIS; Second Applicant: MR GEOFFREY WILLIAM DAVIS; Second Respondent: MR FRANK CULLITY WILSON; Third Respondent: ERNST & YOUNG (A PARTNERSHIP) ABN 75 288 172 749
Jurisdiction
Australia
Judgment Date
21 February 2025
Procedural Posture
Representative Proceedings (shareholder Class Action) / Final Judgment After Trial
Outcome
Applicants' claims dismissed. Consequential orders to be made after the provision of consent or competing orders by parties.
Legal Topics
Misleading or Deceptive Conduct, Financial Reporting, Director's Duties, Auditors' Duties, Negligence, Causation and Damages, Australian Accounting Standards, Australian Auditing Standards
Corporations Law Commercial Law Civil Procedure Misleading or Deceptive Conduct Financial Reporting Director's Duties Auditors' Duties Negligence +3 more

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 17 Party arguments 2
Sign in to unlock

Parties

MR GEOFFREY PETER DAVIS

First Applicant

MR GEOFFREY WILLIAM DAVIS

Second Applicant

MR FRANK CULLITY WILSON

Second Respondent

ERNST & YOUNG (A PARTNERSHIP) ABN 75 288 172 749

Third Respondent

Procedural Posture

Representative Proceedings (shareholder Class Action) / Final Judgment After Trial

Legal Issues

  1. 1 Whether the applicants relied on misleading or deceptive conduct in relation to the purchase of shares
  2. 2 Whether representations in financial reports complied with applicable standards and were held on reasonable grounds
  3. 3 Whether the Managing Director and Auditor breached their duties under the Corporations Act and ASIC Act

Ratio Decidendi

Applicants failed to establish that the assumptions used in the DCF Model for valuing biological assets were unrealistic and materially overstated the accounts as alleged. The factual predicates for misleading or deceptive conduct were not established, and the counterfactual case upon which causation and loss depended was not made out. Accordingly, liability under the Corporations Act, ASIC Act, and at common law was not established.

Court Disposition

Applicants' claims dismissed. Consequential orders to be made after the provision of consent or competing orders by parties.

Orders

  • On or by 7 March 2025 the parties are to provide to the Associate to Shariff J consent orders, including answers to the Common Questions, giving effect to the reasons for judgment. If consent cannot be reached, each party is to provide competing orders.
  • Parties to confer as to the appropriate costs order. If not agreed, applications and submissions regarding costs are to be made according to the timetable set in orders 2 and 3.